PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 160.00
-1.00 (-0.62%)
Sep 16, 2026, 3:30 PM JST
PRISM BioLab Co.,LTD Market Cap
PRISM BioLab Co.,LTD has a market cap or net worth of 5.95 billion as of September 15, 2026. Its market cap has decreased by -5.10% in one year.
Market Cap
5.95B
Enterprise Value
3.62B
Revenue
737.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
160.00
ChartMarket Cap Chart
Since July 2, 2024, PRISM BioLab Co.,LTD's market cap has decreased from 17.84B to 5.95B, a decrease of -66.64%. That is a compound annual growth rate of -39.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 5.95B | 3.34% |
| Dec 30, 2025 | 5.76B | -44.77% |
| Dec 30, 2024 | 10.43B | -41.56% |
| Jul 2, 2024 | 17.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ADR Biomedical Holdings | 7.44B |
| SUSMED,Inc. | 6.84B |
| Chiome Bioscience | 6.79B |
| MEDINET | 6.78B |
| CellSource | 6.31B |
| Cyfuse Biomedical K.K. | 6.05B |
| Noile-Immune Biotech | 6.03B |
| Soiken Holdings | 5.57B |